Home › Funds › DAFNA Capital Management LLC › MPLT
DAFNA Capital Management LLC position in MPLT
MAPLIGHT THERAPEUTICS INC · Health Care
DAFNA Capital Management LLC reported holding 155,579 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.34% of its reported portfolio and ranking #48 among its reported holdings. DAFNA Capital Management LLC has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How DAFNA Capital Management LLC's MPLT position evolved
DAFNA Capital Management LLC first disclosed a stake in MPLT in Q4 2025 at 143,764 shares (US$2.5M). The position peaked in Q2 2026 at 171,006 shares, worth US$6.1M. Across 4 filings, DAFNA Capital Management LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 155,579 shares valued at US$1.6M — a reduction of -15,427 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 143.76K | $2.53M | New |
| Q1 2026 | 171.01K | $3.48M | Add |
| Q2 2026 | 171.01K | $6.13M | Hold |
| Q3 2026 | 155.58K | $1.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MPLT and 13F data
MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 81 other funds we track also report a position in MPLT — the largest reported positions include FCPM III SERVICES B.V. (US$45.1M), Nan Fung Group Holdings Ltd (US$23.4M), Novo Holdings A/S (US$21.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MPLT
- FCPM III SERVICES B.V. 4.43M sh · $45.12M · Q3 2026
- Nan Fung Group Holdings Ltd 2.30M sh · $23.44M · Q3 2026
- Novo Holdings A/S 2.09M sh · $21.26M · Q3 2026
- Sanofi 912.04K sh · $9.29M · Q3 2026
- 5AM Venture Management, LLC 741.89K sh · $7.56M · Q3 2026
- Velan Capital Investment Management LP 624.70K sh · $6.37M · Q3 2026
- Pivotal bioVenture Partners Investment Advisor LLC 611.45K sh · $6.23M · Q3 2026
- Blue Owl Capital Holdings LP 556.37K sh · $5.67M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 118.30K sh · $1.21M · Q3 2026
More on DAFNA Capital Management LLC
FAQ
How long has DAFNA Capital Management LLC held MPLT?
DAFNA Capital Management LLC has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is DAFNA Capital Management LLC's current position in MPLT?
As of Q3 2026, DAFNA Capital Management LLC holds 155.58K shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $1.59M, representing 0.34% of its reported portfolio and ranking #48.
Has DAFNA Capital Management LLC been buying or selling MPLT?
In the latest 13F filing (Q3 2026), DAFNA Capital Management LLC reduced its position in MPLT. The position peaked in Q2 2026 at 171.01K shares.
Which other funds hold MPLT?
Other major institutional holders of MPLT include FCPM III SERVICES B.V., Nan Fung Group Holdings Ltd, Novo Holdings A/S, among 81 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.